反応式
[Cl:1][CH2:2][CH2:3][CH2:4][C:5](Cl)=[O:6].[CH:8]1[C:18]2[C:17](=[O:19])[NH:16][C:15]3[CH:20]=[CH:21][CH:22]=[CH:23][C:14]=3[NH:13][C:12]=2[CH:11]=[CH:10][CH:9]=1>CC(C)=O>[Cl:1][CH2:2][CH2:3][CH2:4][C:5]([N:13]1[C:12]2[CH:11]=[CH:10][CH:9]=[CH:8][C:18]=2[C:17](=[O:19])[NH:16][C:15]2[CH:20]=[CH:21][CH:22]=[CH:23][C:14]1=2)=[O:6]参加物
4
実験手順
A mixture of 4-chlorobutyryl chloride (3.5 g) and 10,11-dihydrodibenzo[b,e][1,4]diazepin-11-one (4.2 g) (J. Med. Chem., 1963, 6, 767) in acetone (90 ml) was heated under reflux for 8 hours and evaporated. The residue was purified by chromatography on silica using hexane plus 0-100% dichloromethane as eluant. Appropriate fractions were combined and evaporated and the residue triturated with hexane/dichloromethane to give the title compound as a colourless solid, 1.62 g (26%), m.p. 151°-152° C.
後処理
- temperaturewas heated
- temperatureunder reflux for 8 hours
- customevaporated
- customThe residue was purified by chromatography on silica
- customevaporated
- customthe residue triturated with hexane/dichloromethane
出典と根拠
- ORDレコード
- ord-79eaf72784de43c4af5c7a91e5d67ae8
- 出典データセット
- uspto-grants-1995_05
- 特許番号
- US05418229
関連ノート
読み込み中…